NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
Clinical Considerations for the Treatment of Schizophrenia
Guest: Craig Chepke, MD, FAPA
Schizophrenia is a chronic mental disorder characterized by sympto…
Investigating the Link Between Hypertension Medications & Dementia
Guest: Zachary Marcum, PharmD, PhD
Hypertension affects nearly half of adults in the United Stat…
Investigating the Link Between Hypertension Medications & Dementia
Guest: Zachary Marcum, PharmD, PhD
Hypertension affects nearly half of adults in the United Stat…
B-Cell Therapy: When Is It Right for Our MS Patients?
Guest: Andrew Chan, MD
Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple sclerosis (MS), but their exact …
B-Cell Therapy: When Is It Right for Our MS Patients?
Guest: Andrew Chan, MD
Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple sclerosis (MS), but their exact …
Alzheimer’s Disease: What’s The Latest Research?
Guest: Peter Whitehouse, MD, PhD
Guest: Daniel George, MSc, PhD
Although there’s still no cure for Alzheimer’s disease, we’ve made great strid…
Alzheimer’s Disease: What’s The Latest Research?
Guest: Peter Whitehouse, MD, PhD
Guest: Daniel George, MSc, PhD
Although there’s still no cure for Alzheimer’s disease, we’ve made great strid…
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
Guest: Peter Whitehouse, MD, PhD
The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversia…
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
Guest: Peter Whitehouse, MD, PhD
The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversia…
Keys to Closing the Gender Gap in Stroke Trials
Guest: Cheryl Carcel, MD, PhD
Although research suggests that women have a similar stroke risk a…
Keys to Closing the Gender Gap in Stroke Trials
Guest: Cheryl Carcel, MD, PhD
Although research suggests that women have a similar stroke risk a…
Diagnosing Mental Illness with the Perspectives Approach
Guest: Margaret Chisolm, MD
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook traditionally used by healthcare pro…
Diagnosing Mental Illness with the Perspectives Approach
Guest: Margaret Chisolm, MD
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook traditionally used by healthcare pro…
Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics
Guest: Jose Rubio, MD
Schizophrenia is rarely a single-episode illness. In fact, 8 out of 10 pat…
Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics
Guest: Jose Rubio, MD
Schizophrenia is rarely a single-episode illness. In fact, 8 out of 10 pat…
Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients
Guest: Vikram V. Bhise, MD
Pediatric multiple sclerosis (MS) occurs in more than 8,000 children in the United States alone, but there’s little data regarding t…
Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients
Guest: Vikram V. Bhise, MD
Pediatric multiple sclerosis (MS) occurs in more than 8,000 children in the United States alone, but there’s little data regarding t…
A Recap of the Rehabilitation Track at CMSC
The rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) was filled with key updates regarding collaboration, nonpharmace…
The Importance of Collaboration in MS Care: Takeaways from CMSC
A multidisciplinary approach to multiple sclerosis (MS) is becoming more and more integral in practice as research continues to emerge on its signifi…
A Recap of the Rehabilitation Track at CMSC
The rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) was filled with key updates regarding collaboration, nonpharmace…